Proceedings of The Lancet Conference on Healthcare-Associated Infections

Size: px
Start display at page:

Download "Proceedings of The Lancet Conference on Healthcare-Associated Infections"

Transcription

1 Proceedings of The Lancet Conference on Healthcare-Associated Infections London, UK, December 2008 Guest Editor: Professor Kevin G. Kerr

2 The Official Journal of the Hospital Infection Society Editor S. J. Dancer (Glasgow) Assistant Editors S. P. Barrett (London) J. Bates (Worthing) A. Berrington (Sunderland) J. Child (Worthing) R. Cooke (Liverpool) A. Guyot (Guildford) P. N. Hoffman (London) H. Humphreys (Dublin) T. Inkster (Glasgow) K. Jacobson (Bristol) P. Jumaa (Birmingham) K. G. Kerr (Harrowgate) G. McDonnell (Basingstoke) A. J. Mifsud (London) S. W. B. Newsom (Cambridge) B. Oppenheim (Birmingham) S. Schelenz (Norwich) P. Shears (Wirral) R. C. Spencer (Bristol) J. Stephenson (Surrey) J. Stockley (Worcester) E. L. Teare (Chelmsford) A. M. Walker (Pentraeth) A. P. R. Wilson (London) Reviews I. M. Gould (Aberdeen) Editorial Coordinator N. Atherton Editorial Board P. Astagneau (France) T. S. J. Elliott (Birmingham) A. P. Fraise (Birmingham) C. M. Fry (London) G. Gopal Rao (London) K. Gould (Newcastle) J.-J. Haxhe (Belgium) A. Holmes (London) P. P. Mortimer (London) R. N. Olmsted (USA) J. Philpott-Howard (London) G. L. Ridgway (London) M. Rotter (Austria) E. T. M. Smyth (Belfast) Editorial Advisers G. Ayliffe (UK) F. Daschner (Germany) G. L. French (London) O. B. Jepsen (Denmark) H. Kobayashi (Japan) S. Mehtar (South Africa) J. W. Pearman (Australia) G. Reybrouck (Belgium) H.-G. Sonntag (Germany) A. Voss (Netherlands) Hospital Infection Society Office 162 Kings Cross Road, London WC1X 9DH Tel: Chief Executive Dr T. R. Logan President Dr G. L. Ridgway 162 King s Cross Road, London WC1X 9DH Chairman Dr A. P. Fraise Department of Clinical Microbiology, University Hospital Birmingham NHS Foundation Trust, Queen Elizabeth Medical Centre, Edgbaston, Birmingham B15 2TJ Secretary Ms C. Fry Department of Health, Wellington House, Waterloo Road, London SE1 8UG Scientific Secretary Dr T. C. Boswell Department of Microbiology, Queens Campus, Nottingham University Hospitals NHS Trust, Derby Road, Nottingham NG7 2UH Treasurer Dr W. A. Telfer Brunton Department of Clinical Microbiology, Royal Cornwall Hospitals NHS Trust, Penventinnie Lane, Treliske, Truro TR1 3LQ Correspondence G. D. Corcoran (Cork)

3 VOLUME 73 ISSUE 4 DECEMBER 2009 The Hospital Infection Society The authors, editors, owners and publishers do not accept any respon sibility for any loss or damage arising from actions or decisions arising from information contained in this publication; ultimate responsibility for the treatment of patients lies with the medical practitioner. The opinions expressed are those of the authors and the inclusion in this publication of material relating to a particular product, method or technique does not amount to an endorsement of its value or quality, or of the claims made by its manufacturers. Abstracted/Indexed by: Current Contents, ASCA, Science Citation Index, Infomed, Index Medicus, Medline, EMBASE/Excerpta Medica, Abstracts of Hygiene, Communicable Disease and Tropical Diseases Bulletin and Cumulative Index to Nursing and Allied Health Literature. Contents Introduction Healthcare-associated infection: moving behind headlines to clinical solutions D. Pittet 293 Reviews Historical and changing epidemiology of healthcare-associated infections A. Pearson 296 Role of hand hygiene in healthcare-associated infection prevention B. Allegranzi and D. Pittet 305 Preventing surgical site infection. Where now? H. Humphreys 316 Intravascular catheter infections J. Edgeworth 323 Noroviruses in healthcare settings: a challenging problem M. Koopmans 331 Pseudomonas aeruginosa : a formidable and ever-present adversary K.G. Kerr and A.M. Snelling 338 Extended-spectrum -lactamase-producing organisms M.E. Falagas and D.E. Karageorgopoulos 345 Acinetobacter: an old friend, but a new enemy K.J. Towner 355 Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections R.L. Skov and K.S. Jensen 364 Screening and isolation for infection control E. Tacconelli 371 The role of environmental cleaning in the control of hospital-acquired infection S.J. Dancer 378 Controversies in infection: infection control or antibiotic stewardship to control healthcare-acquired infection? I.M. Gould 386 Where does infection control fit into a hospital management structure? E.T. Brannigan, E. Murray and A. Holmes 392

4 Hand hygiene and infection in hospitals: what do the public know; what should the public know? M. Fletcher 397 What are the drivers of the UK media coverage of meticillin-resistant Staphylococcus aureus, the inter-relationships and relative influences? T. Boyce, E. Murray and A. Holmes 400 Are national targets the right way to improve infection control practice? M. Millar 408 Responsibility for managing healthcare-associated infections: where does the buck stop? B.I. Duerden 414 Letter to the Editor Review of Lancet conference on healthcare-associated infections M. Meda 418

5 Journal of Hospital Infection (2009) 73, 293e295 Available online at INTRODUCTION Healthcare-associated infection: moving behind headlines to clinical solutions D. Pittet* Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, 4 Rue Gabrielle- Perret Gentil, 1211 Geneva 14, Switzerland Available online 12 October 2009 Introduction Healthcare-associated infection (HCAI) is universal and complicates patient care both in developed and developing countries. Worldwide, it is estimated that as many as 1.4 million patients acquire infections each day in hospitals alone. 1 Recognising that HCAI prevention is of paramount importance on the current patient safety agenda, The Lancet organised an international conference on HCAI in London in December What did we learn? Our old friendsdmeticillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Pseudomonas aeruginosa, Acinetobacter spp., and Clostridium difficiled continue to challenge healthcare settings worldwide. An MRSA pandemic is ongoing and strains are capable of acquiring new virulence factors in addition to multiple resistance. Rapid diagnosis seems useful, but only in conjunction with preventive actions. The screening of target populations deserves further investigation, whereas universal screening appears to be neither effective nor cost-effective. The role of antibiotic * Tel.: þ ; fax: þ address: didier.pittet@hcuge.ch pressure on the MRSA reservoir deserves controlled interventions. Importantly, MRSA control is feasible and many examples are available at hospital, regional, or even national levels. VRE spread continues to represent a paradox on both sides of the Atlantic Ocean. VRE is a coloniser of the gut like Gram-negatives, of theskinlikemrsa,andoftheenvironmentlike C. difficile. Thus,VREcontrolmandatesacomplete, multimodal infection prevention strategy, but is clearly feasible. P. aeruginosa remains a key pathogen in hospitals and causes multiple infections. However, the jury is still out on the role of tap-to-patient and patient-to-tap crosstransmission as the reservoir/source. Should P. aeruginosa be considered now as an occupational hazard? Acinetobacter spp. are acquiring pan-resistance to antimicrobials and causing outbreaks, particularly among specific patient populations. In particular, their capacity for long-term survival in the environment complicates control. Should we propose a zero tolerance for P. aeruginosa and Acinetobacter spp.? Extended-spectrum b-lactamase-producing enterobacteriaceae (ESBLs) are now becoming universal with multiple, complex resistance mechanisms that differ worldwide, and studies are needed to better delineate their epidemiology and control. The emergence of a new C. difficile strain over the past years has highlighted major failures in patient safety. Large /$ - see front matter ª 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved. doi: /j.jhin

6 294 D. Pittet differences in the disease epidemiology and control are observed among hospitals and countries, but control is feasibledeven at country level. Our old friends are going public: community pathogens are now entering the hospital. Examples include ESBLs and community-acquired MRSA. Norovirus outbreaks originating in the community are affecting institutionalised patient populations, sometimes with devastating consequences. And finally, C. difficile is now responsible for severe community infections among young adults and non-immunocompromised populations in contrast to its more traditional role previously restricted to healthcare settings. Are there clinical solutions? Targeted HCAI prevention is clearly effective. Prevent intravascular line infection? e Yes, we can! How? By using multimodal intervention strategies, sometimes also called bundles. Prevent surgical site infection? e Yes, we possibly can. Again, by decreasing several risk factors, in particular, by the optimal and timely use of perioperative antibiotic prophylaxis. Preventing ventilator-associated pneumonia remains difficult and complex, but is certainly possible using multimodal interventions whose components still need to be defined. In particular, there is a pressing need to revisit the content of the currently proposed bundle strategies. The critical role of setting targets for practice improvement needs to be reviewed, especially at national level. First, healthcare systems should decide what and how to measure. Other questions that follow are: what are the best interventions to implement? What are the targets for improvement? Targets should be set locally considering feasibility and cost-effectiveness. Risk taking is an integral part of healthcare, similar to leadership. In the UK, mandatory surveillance, public reporting, and the setting of performance targets have clearly provided effective leverage. Towards integrated solutions Hand hygiene remains the key measure for HCAI prevention. As illustrated by the successful implementation of the Clean Care is Safer Care multimodal strategy proposed by the World Health Organization First Global Patient Safety Challenge and launched in 2005, promotion is feasible and effective worldwide ( gpsc/en). 2 Although environmental control must improve in most healthcare settings with special emphasis on hand-touch sites, it is not the sole responsibility of the infection control team. Cleanliness is everyone s business, from housekeeping to executive staff and board members. There is a clear link between antimicrobial use and resistance at all levels; ward, hospital, regional, country, and even continental. As shown recently through successful nationwide campaigns, the impact of antibiotic control is easier to demonstrate in the community. Infection control teams in hospitals have traditionally worked as fire-fighters and now need to move on to more prevention-oriented stewardship. When wellorganised and effective, antimicrobial stewardship is largely cost-effective. Infection control must be integrated into the hospital management structure at all levels, including the decision-making process. It should use a system-based approach to ensure sustainability, be viewed as a corporate priority, and be based on corporate accountability and institutional leadership. Performance management tools related to infection control metrics are available and HCAI rates can be used as a proxy indicator for differences in system management. The best healthcare model needs to deliver effective, reliable and resilient infection prevention. Should we go public? HCAI is a topic of high public and media interest. However, this increased openness and transparency could also result in a rising concern about the infection risk. As a consequence of the public right to know, public reporting and performance benchmarking is increasingly well-established in several countries. But does it make a difference to the HCAI risk in hospitals and other healthcare settings? Martin Fletcher reviews the evidence on publication reporting and proposes actions for boards and senior leaders to improve the institutional safety culture. 3 He suggests hand hygiene promotion as an exemplar model for increasing patient safety at institutional, regional, or even national level, and the necessity to allow patients to participate in this continuous and complex challenge. It follows, therefore, that communication at all levels must be optimised in the field of infection prevention; it must consider the public right to know, allow patients and families to participate, and work in synergy with the media in multidisciplinary forums that include patients, healthcare workers, scientists, journalists and politicians.

7 Healthcare-associated infection 295 Infection control is moving behind the headlines to guarantee safer healthcare by applying effective clinical solutions and by conducting research where needed. Infection control is no longer optional. For the sake of every patient in our care, the healthcare community across the globe must make every effort to ensure that it is fully integrated into each institution s management structure. References 1. Lynch P, Pittet D, Borg MA, Mehtar S. Infection control in countries with limited resources. J Hosp Infect 2007; 65(Suppl. 2):148e Pittet D, Donaldson L. Clean Care is Safer Care: a worldwide priority. Lancet 2006;366:1246e Fletcher M. Hand hygiene and infection in hospitals: what do the public know; what should the public know? J Hosp Infect 2009;73: 397e399.

8 Journal of Hospital Infection (2009) 73, 296e304 Available online at REVIEW Historical and changing epidemiology of healthcare-associated infections A. Pearson a,b, * a Department of HCAI & AMR, Centre for Infections, London, UK b Department of Advanced Computational Biology, University of Maryland, College Park, Maryland, USA Available online 3 November 2009 KEYWORDS Clostridium difficile; Healthcare-associated infection; Medical history; MRSA; Surveillance Summary This review compares the historical perspectives on healthcare-associated infections (HCAIs) with the current changing epidemiological picture as it relates to these infections. Evidence in support of these changes is given using trends in mortality for Clostridium difficile and meticillin-resistant Staphylococcus aureus bacteraemia in England as examples. The impact of current intervention programmes which target these, and other HCAIs, is also considered and knowledge gaps and options for changes in public health strategy required to achieve further reductions in HCAIs in the National Health Service in England are identified. ª 2009 Published by Elsevier Ltd on behalf of The Hospital Infection Society. Historical perspectives In the fourth century BC, Hippocrates, the father of western medicine, is generally attributed as having introduced the need to use treatments for the benefit of the ill in accordance with my ability and my judgment, but from what is to their harm and injustice I will keep them. This is one of a series of statements that were subsequently referred to as the Hippocratic Oath. The oath was an ancient protocol in medicine at the time of Hippocrates although it may not have been * Corresponding address: Department of HCAI & AMR, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK. address: dandrewpearson@googl .com strictly attributable to him. Subsequently the protocol has been adopted universally by medical schools and accreditation bodies including the General Medical Council in the UK. 1 By the twenty-first century AD the Institute for Health Improvement in its 5 Million Lives campaign had enhanced the definition of medical harm as: Unintended physical injury resulting from or contributed to by medical care, including the absence of indicated medical treatment, that requires additional monitoring, treatment or hospitalisation, or that results in death. Such injury is considered harm whether or not it is considered preventable, whether or not it resulted from a medical error or it occurred within a hospital /$ - see front matter ª 2009 Published by Elsevier Ltd on behalf of The Hospital Infection Society. doi: /j.jhin

9 Historical and changing epidemiology of healthcare-associated infections 297 Through the following centuries the Egyptians and Europeans clearly enunciated their interest in medical oversight and culpable negligence. In Egypt, Moses ben Maimon practised and taught medicine insisting on cleanliness as the physician s best friend: Never forget to wash your hands after having touched a sick person and I dismount from my animal, wash my hands, go forth to my patients. In Europe by the nineteenth century several physicians developed further the realisation of the importance of hand washing. Dr Ignaz Semmelweis, the Hungarian-born physician, generally regarded as the father of infection control practice, was responsible in 1847 for the maternity service of the Allgemeine Krankenhaus teaching hospital in Vienna. There he observed that women delivered by physicians and medical students had a much higher rate of post-delivery mortality (13e18%) than women delivered by midwives or trainee midwives (2%). Earlier, less well-evidenced, statements are attributed to Oliver Wendell Holmes: Let the men who mould opinions here look to it; if there is any interested oversight, any culpable negligence and the facts shall reach the public ear, the pestilence-carrier of the lying-in chamber must look to God for pardon, for man will never forgive him. The work of Florence Nightingale in October 1854 and April 1855 made a meticulous analysis of the mortality data and identified poor sanitation as the underlying cause as well as creating new statistical diagrams that persuaded government to reform health. This development of a modernday analytical approach to patient outcome was the evidence base for her Notes on hospitals. This had a profound impact on the design and management of hospitals as it tackled problems of overcrowding in civil hospitals, poor ventilation and lack of cleanliness and reported deaths from preventable diseases, deaths from wounds and deaths from all other causes. HCAI in the twenty-first century The contribution of deaths from HCAI to the total lives lost per year has been estimated by Amalberti who compared healthcare with ultrasafe activities such as flying with scheduled airlines, the nuclear power industry, road traffic deaths, and with dangerous activities such as bungee jumping and mountain climbing. 2 The risk from healthcare is further exemplified by reference to the published mortality reports for C. difficile and meticillin-resistant Staphylococcus aureus (MRSA). Figures 1 and 2 respectively show the UK trends for increasing numbers of death certificates reporting as a cause of death or mentioning C. difficile (1993e2007) and MRSA (1999e 2007). These trends are subject to ascertainment bias as clinicians may change their threshold for notifying deaths due to HCAI. National surveillance and evidence for the changing epidemiology of C. difficile infection Case surveillance based on laboratory reporting is accepted as the most reliable routinely available information by which to measure changes in incidence. In England there are two surveillance systems for measuring S. aureus (including MRSA) and C. difficile infection: voluntary laboratory reporting (LabBase electronic reporting system) and the Department of Health-initiated mandatory MRSA bacteraemia and C. difficile surveillance programmes. The increase in laboratory-confirmed cases of C. difficile infection (CDI) reported to the voluntary national laboratory reporting system between 1990 and 2007 is shown in Figure 3. These English National Health Service (NHS)-based laboratories receive specimens from both hospital and community patients across the whole NHS. Ascertainment during this time varied from around 45% in 1990 to 70% in Notwithstanding this increased reporting there was a steady increase from 1990 to 2001, after which there was an accelerating rate of increase recognised in retrospect as related to the emergence of newly recognised hyper-toxin-producing strains of C. difficile. Figure 3 also indicates the timelines for the introduction of mandatory surveillance of laboratory-confirmed cases of CDI, mandatory strain surveillance and mandatory enhanced surveillance to monitor a performance target to reduce CDI. In addition the UK Treasury s Public Service Delivery Agreement, published in 2007, introduced a target for a 30% reduction in the number of cases of CDI reported by English NHS hospitals in 2010e11 compared with an agreed baseline in 2007e8. The impact of this mandatory surveillance programme and the setting of a 30% reduction target is seen in Figure 4. Data from the voluntary surveillance shows ascertainment for patients 65 years as 77e85% of the mandatory scheme for each quarter between April 2007 and March So mandatory surveillance, public reporting and the setting of a performance target was highly effective at increasing ascertainment. This intervention might

10 298 A. Pearson Underlying cause Mentions No. of deaths Year Figure 1 Number of deaths reported with C. difficile as underlying cause or mentioned 1993e2007. Data from the UK Office of National Statistics. itself be expected to influence physicians behaviour. During 2006 and 2007 the Department of Health (DoH) launched the Saving Lives campaign with a High Impact Intervention care bundle to guide physicians and clinical teams in the prevention of CDI. 3 The overall impact of introducing mandatory surveillance, the Saving Lives campaign and the follow-up of NHS trusts against the Underlying cause Mentions No. of deaths Figure 2 Number of deaths reported with MRSA as underlying cause or mentioned 1999e2007. Data from the UK Office of National Statistics. Year

11 Historical and changing epidemiology of healthcare-associated infections 299 C. difficile counts Year Figure 3 Voluntary NHS laboratory C. difficile surveillance. Timeline for introduction of mandatory surveillance: 2004, mandatory surveillance introduced; 2005, mandatory strain sampling introduced; 2007, mandatory enhanced surveillance introduced. Source: Health Protection Agency LabBase Voluntary Reports; Department of Health Mandatory Surveillance Reports. performance target by a DoH-based improvement team has had a remarkable effect within the first full year of the programme. Figure 5 compares the pattern of changes in rates of CDI per 1000 bed-days. Marked variation across the English NHS underlines both the variability and opportunity for further health gain that exists across the NHS. The enhanced surveillance programme has also begun to provide an insight as to the incidence of CDI in patients aged <65 years as well as in the general population diagnosed with CDI in non-acute care settings. Measurement and the interpretation of enhanced surveillance data from the mandatory scheme is complex but initial analysis indicates that an average of 29% of CDI cases would fit a definition of community-acquired infection based on three categories of specimen: on-presentation cases, cases developing less than 2 days after admission, and non-acute specimens. Aggregate analysis may hide important local variation. This is the case with CDI in the community. The proportion of community CDI cases in local NHS trusts varies markedly from 0 to >55% in a small number of localities. These findings are newly recognised and under further investigation by both epidemiologists and local microbiologists. Early indications are that, as in the past, a proportion of CDI cases do not have either exposure to antibiotics or healthcare as risk factors for their infection. National surveillance and evidence for the reduction in MRSA bacteraemia The laboratory-based voluntary system showed a steep rise in the reported number of MRSA bacteraemia cases between 1990 and 2001 (Figure 6). In 2001, the Chief Medical Officer noted that the prevalence of methicillin-resistant S. aureus has increased markedly in the last decade, primarily associated with hospital acquired infection. 4 Mandatory reporting of MRSA and meticillin-susceptible S. aureus (MSSA) bacteraemia was introduced for all NHS acute trusts in England in April Enhanced mandatory surveillance was initiated in 2005 which allows cases to be entered in real time and collects more detailed information regarding the incidence and risks of infection. The voluntary reporting system continues to operate alongside the mandatory surveillance scheme. Voluntary surveillance will underestimate the true number of MRSA bacteraemia cases (data not shown). Ascertainment is affected by the number of NHS trusts contributing voluntary data and the completeness of these data, both of which are likely to have varied over time. In total, reports of MRSA bacteraemia were made via LabBase between 2002 and The introduction of mandatory reporting to the web increased this number to Mandatory reporting had the greatest impact in the first year when reporting increased by 49% from 4879 to 7274 cases.

12 300 A. Pearson C. difficile counts Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Quarter Figure 4 Comparison of Mandatory and Voluntary NHS laboratory C. difficile surveillance. Solid black line: mandatory 65 years; solid grey line: voluntary 65 years; dashed line: mandatory 2e64 years; dotted line: voluntary 2e64 years. Source: Health Protection Agency LabBase Voluntary Surveillance Reports.

13 Historical and changing epidemiology of healthcare-associated infections C. difficile rate per 1000 bed-days East of England East Midlands London North East North West South East South West West Midlands Yorkshire & Humber HPA Region Figure 5 Regional C. difficile rate per 1000 bed-days. HPA, Health Protection Agency. Source: Department of Health Mandatory MRSA bacteraemia surveillance.

14 302 A. Pearson S. aureus bacteraemia counts MRSA MSSA No susceptibility Year Figure 6 Staphylococcus aureus bacteraemia voluntary laboratory reporting 1990e2006: meticillin sensitivity reported by English NHS acute trusts. Comparison of the reported numbers to 2008 showed that mandatory reporting has increased ascertainment by between approximately 900 and 2300 cases per year to 39%. The impact of introducing mandatory surveillance, the Saving Lives campaign and the use of improvement teams by the DoH along with a national cleanyourhands campaign has effected the required national reduction of 50% by June 2008 (Figure 7). Again the introduction of mandatory enhanced surveillance of MRSA bacteraemia cases gave a new insight to the epidemiology as it demonstrated that only 65% of cases were acquired during the current hospital admission whereas 34% were reported from patients who were recent admissions from the community or non-acute care facilities. Voluntary submitted risk factor data on 3495/ (28%) cases reported to the mandatory surveillance system between May 2006 and December 2008 indicated key information on the sources of MRSA bacteraemia and highlighted the importance of vascular lines, skin and soft tissue infections as well as other localised infections and urinary tract infections as potentially preventable sources of infection. This is invaluable information on which to base local strategies to further reduce MRSA bacteraemia. So, with the introduction of mandatory surveillance, HCAI has been made a visible and unambiguous indicator of quality and safety of patient care and the Health Protection Agency has provided the NHS with high quality information for the public, patients and clinical teams so that the risks associated with the performance of certain procedures are transparent. Worldwide data on measurement of HCAI is remarkable in its inadequacy. An editorial from leading US senators compared measurement in healthcare and baseball and cited that: Remarkably, a doctor today can get more data on the starting third baseman on his baseball team than on the effectiveness of life-and-death medical procedures. Studies have shown that most health care is not based on clinical studies of what works best. Instead, most care is based on informed opinion, personal observation or tradition. To deliver better health care, we should learn from the successful teams that have adopted baseball s new evidence-based methods. The best way to start improving quality and lowering costs is to study the stats. In the past decade, baseball has experienced a datadriven information revolution. Numbers-crunchers now routinely use statistics to put better teams on the field for less money. Our overpriced, underperforming health care system needs a similar revolution. To deliver better health care, we should learn from the successful teams that have adopted baseball s

15 Historical and changing epidemiology of healthcare-associated infections MRSA bacteraemias reported Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Quarter Figure 7 Reduction of mandatory MRSA bacteraemia surveillance 2005e2008. Sources: NHS Mandatory and Voluntary MRSA bacteraemia surveillance. new evidence-based methods. The best way to start improving quality and lowering costs is to study the stats. 5 The introduction into the English NHS of a webenabled reporting and user access networked mandatory surveillance system has addressed this deficiency in measurement for a limited number of infections currently targeted by mandatory surveillance and performance management. Knowledge gaps Encouraging though these trends are, current gaps in our knowledge relating to healthcare-associated infection need to be addressed if further reductions in these infections are to be achieved. These include introduction of robust surveillance systems to monitor infections other than those related to MRSA bacteraemia and C. difficile. This should include systematic population-based epidemiological surveillance. Technologies which permit realtime strain characterisation and real-time patient tracking will assist infection control teams in preventing as well as controlling clusters of infection in hospitals at the local level but rapid strain characterisation will be invaluable in recognising changes not only in local but also in regional and national epidemiology. Similarly, real-time electronic prescribing systems will allow enhanced antibiotic audit and better analysis of antibiotic misprescribing which, in turn, will help in efforts to control CDI and antimicrobial resistance. Selective use of improved evidence-based performance management interventions such as reduction targets, never events and zero tolerance will also be beneficial. Finally development and refinement of tools which permit assessment of new interventions to identify how they can be deployed in a cost-effective manner remains a key priority. Conflict of interest statement None declared.

16 304 A. Pearson Funding sources None. References 1. General Medical Council. Good medical practice: the duties of a doctor registered with the General Medical Council. London: GMC; Amalberti R. The paradoxes of almost totally safe transportation systems. Saf Sci 2001;37:109e Department of Health. Saving Lives: a delivery programme to reduce healthcare associated infection including MRSA. London: DoH; Department of Health. CMO s update 30: surveillance of healthcare associated infections. London: DoH; Beane W, Gingrich N, Kerry J. How to take American health care from worst to first. New York Times Online, 24 October 2008.

17 Journal of Hospital Infection (2009) 73, 305e315 Available online at REVIEW Role of hand hygiene in healthcare-associated infection prevention B. Allegranzi a, *, D. Pittet a,b a World Alliance for Patient Safety, World Health Organization, Geneva, Switzerland b Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland Available online 31 August 2009 KEYWORDS Alcohol-based hand rub; Hand hygiene; Healthcare-associated infection; Intervention; Patient safety; Promotion; World Health Organization Summary Healthcare workers hands are the most common vehicle for the transmission of healthcare-associated pathogens from patient to patient and within the healthcare environment. Hand hygiene is the leading measure for preventing the spread of antimicrobial resistance and reducing healthcare-associated infections (HCAIs), but healthcare worker compliance with optimal practices remains low in most settings. This paper reviews factors influencing hand hygiene compliance, the impact of hand hygiene promotion on healthcare-associated pathogen cross-transmission and infection rates, and challenging issues related to the universal adoption of alcohol-based hand rub as a critical system change for successful promotion. Available evidence highlights the fact that multimodal intervention strategies lead to improved hand hygiene and a reduction in HCAI. However, further research is needed to evaluate the relative efficacy of each strategy component and to identify the most successful interventions, particularly in settings with limited resources. The main objective of the First Global Patient Safety Challenge, launched by the World Health Organization (WHO), is to achieve an improvement in hand hygiene practices worldwide with the ultimate goal of promoting a strong patient safety culture. We also report considerations and solutions resulting from the implementation of the multimodal strategy proposed in the WHO Guidelines on Hand Hygiene in Health Care. ª 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved. * Corresponding author. Address: First Global Patient Safety Challenge, World Alliance for Patient Safety, IER/PSP, Room L319, L Building, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. Tel.: þ ; fax: þ address: allegranzib@who.int /$ - see front matter ª 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved. doi: /j.jhin

18 306 B. Allegranzi, D. Pittet Introduction Numerous studies document the pivotal role of healthcare workers (HCWs) hands in the propagation of micro-organisms within the healthcare environment and ultimately to patients. 1 As recently described, patient-to-patient transmission of pathogens via HCWs hands involves five sequential steps. 2 Patients skin can be colonised by transient pathogens that are subsequently shed onto surfaces in the immediate patient surroundings, thus leading to environmental contamination. 2 As a consequence, HCWs contaminate their hands by touching the environment or patients skin during routine care activities, sometimes even despite glove use. 2 It has been shown that organisms are capable of surviving on HCWs hands for at least several minutes following contamination. 2 Thus, if hand hygiene practices are suboptimal, microbial colonisation is more easily established and/or direct transmission to patients or a fomite in direct contact with the patient may occur. 2 Based on this evidence and the demonstration of its effectiveness, optimal hand hygiene behaviour is considered the cornerstone of healthcareassociated infection (HCAI) prevention. 2e4 Furthermore, not only is it a key element of standard and isolation precautions, but its importance is emphasised also in the most modern bundle approaches for the prevention of specific site infections such as catheter-related bloodstream infection (CRBSI), catheter-related urinary tract infection (CRUTI), surgical site infection (SSI), and ventilator-associated pneumonia (VAP). 5e9 Together with other specific prevention measures, environmental cleaning is another essential measure to prevent the spread of some pathogens, particularly Clostridium difficile, vancomycin-resistant enterococci (VRE), norovirus, Acinetobacter spp. and meticillinresistant Staphylococcus aureus (MRSA), and should not be neglected. 10e12 Over the past few years, scientific evidence to support the role of hand hygiene in the improvement of patient safety has increased considerably, but some key controversial issues still challenge care practitioners and researchers. This review summarises the key themes on the role of hand hygiene in preventing HCAI. Interpretations and solutions based on the evidence and experience available through the work of the First Global Patient Safety Challenge of the WHO World Alliance for Patient Safety are suggested. Factors influencing hand hygiene compliance It has been known for many years that HCWs encounter difficulties in complying with hand hygiene indications at different levels. 4 Insufficient or very low compliance rates have been reported from both developed and developing countries. 1,4 Reasons which explain suboptimal practices are multiple and may vary according to the setting and the resources available. For example, the lack of appropriate infrastructure and equipment to enable hand hygiene performance, the cultural background, and even religious beliefs can play an important role in hindering good practices. 13e15 The most frequently observed factors determining poor hand hygiene compliance are: (i) belonging to a certain professional category (i.e. doctor, nursing assistant, physiotherapist, technician); (ii) working in specific care areas (i.e. intensive care, surgery, anaesthesiology, emergency medicine); (iii) understaffing and overcrowding; and (iv) wearing gowns and/or gloves. 1 Unfortunately, hand hygiene indications at higher risk of being neglected are the ones that prevent pathogen transmission to the patient (i.e. before patient contact and clean/aseptic procedures). 1 This is also in concordance with the fact that care activities with a higher risk of cross-transmission lead to a higher risk of poor compliance. 1 Individual factors such as social cognitive determinants may provide additional insight into hand hygiene behaviour. 3,16e18 Many factors play a role in eventually determining either a hand hygiene action or lack of compliance: perception and knowledge of the transmission risk and of the impact of HCAI; social pressure; HCWs conviction of their self-efficacy; the evaluation of perceived benefits against the existing barriers; the intention to perform the hand hygiene action. For instance, intention to wash hands did not predict observed handwashing behaviour in one study, whereas it did in another. 19,20 Hence, hand hygiene behaviour appears not to be homogeneous and can be classified into at least two types of practice. 21 Inherent hand hygiene practice, which drives most community and HCW hand hygiene actions, occurs when hands are visibly soiled, sticky or gritty. On the other hand, elective hand hygiene practice represents those opportunities for hand cleansing not encompassed in the inherent category. Among HCWs, this component of hand hygiene behaviour is similar to many common social interactions, such as shaking hands. During healthcare, it would include touching a patient (e.g. taking a pulse or blood pressure) or

19 Hand hygiene and HCAI prevention 307 having contact with an inanimate object in the patient s surroundings. As they recall a common social behaviour, these contacts do not necessarily trigger an intrinsic need to cleanse hands, although they do involve the risk of cross-transmission. According to behavioural theories, this is the component of hand hygiene most likely to be omitted by busy HCWs and it has been repeatedly confirmed by field observations. Impact of hand hygiene promotion on HCAI Given the complexity of hand hygiene behaviour and the influence of numerous external factors, promotion of good practices is complex and its potential for success depends on the delicate balance between evaluation of benefits and existent barriers. Demonstration of the effectiveness of recommendations and strategies to improve hand hygiene on the ultimate outcome, i.e. the HCAI rate, is crucial in both motivating HCWs behavioural change and securing an investment in this preventive measure by policy-makers and healthcare managers. However, research in this field represents a very challenging activity since methodological and ethical concerns make it difficult to conduct randomised controlled trials with appropriate sample sizes that could establish the relative importance of hand hygiene in the prevention of HCAI. In addition, HCAI surveillance is a very resource- and time-consuming activity requiring rigorous and standardised methods, and therefore is seldom available on a regular and reliable basis. Nevertheless, there is convincing evidence that improved hand hygiene can reduce infection rates. More than 20 hospital-based studies of the impact of hand hygiene on the risk of HCAI have been published between 1977 and 2008 (Table I). 22e45 Of these, some were conducted hospital-wide and report long-term follow-up to demonstrate sustainability. 29,30,38,42 Despite study limitations, almost all reports showed a temporal association between improved hand hygiene practices and reduced infection and cross-transmission rates. Most investigations were conducted in adult or neonatal intensive care units (ICUs) and the large majority introduced the use of alcohol-based hand rubs in association with other promotional components in a multimodal implementation strategy (Table I). Three studies failed to show HCAI reduction following hand hygiene promotion. 24,41,44 In one study, the intervention did not succeed in significantly increasing hand hygiene compliance. 24 In another, the methods and definitions used to detect HCAI were not described and therefore the data reliability cannot be assessed. 44 In a prospective, controlled, cross-over trial, Rupp and colleagues observed no substantial change in device-associated infection rates and infections due to multidrugresistant pathogens, despite a significant and sustained improvement in hand hygiene adherence. 41 Nevertheless, although the study was well designed, it was criticised for lack of screening for cross-transmission, lack of statistical power, and use of an alcohol-based hand rub that failed to meet the EN 1500 standards for antimicrobial efficacy. 46e48 In many countries, the evidence from studies on hand hygiene effectiveness has been convincing enough to motivate governments to invest resources in hand hygiene national and subnational campaigns. 49 However, this evidence mainly reflects findings from interventions implemented in healthcare settings in developed countries. Further research is needed to evaluate the relative efficacy of each key element of multimodal strategies, to assess their implementation feasibility in settings with limited resources, and to gather information on successful solutions allowing adaptation. Among its main objectives, the First Global Patient Safety Challenge, launched by the WHO World Alliance for Patient Safety, intends to make available implementation tools for field use and to assess their validation and adoption in countries at different income levels. 49 Another controversial issue is how significant should be the hand hygiene compliance increase following the intervention in order to be considered satisfactory. No data are available yet to answer this question. Among all the above-mentioned studies, increased compliance rates at follow-up did not exceed 81% (Table I). One study with a follow-up of eight years showed a sustained compliance increase of up to a maximum of 66% and succeeded in parallel to maintain the achieved reduction in HCAI rates of <10%. 29,30 To achieve 100% compliance is not strictly necessary to determine improvement of patient safety at the bedside. On the other hand, the goal of sustained 100% compliance appears unlikely to be achieved because of the complex range of factors influencing HCWs behaviour related to hand hygiene performance. Thus, there is a need for careful consideration before setting a goal of zero tolerance to hand hygiene non-compliance to avoid failure and frustration. Challenging issues related to the adoption of alcohol-based hand rubs The adoption of alcohol-based hand rubs is considered the gold standard for hand hygiene in most

20 308 B. Allegranzi, D. Pittet Table I Most relevant studies assessing the impact of hand hygiene promotion on HCAI (1977e2008) Year Hospital setting 1977 Adult ICU Promotion of hand washing with a chlorhexidine hand cleanser Intervention Impact on hand hygiene compliance Impact on HCAI Duration of follow-up NA Significant reduction (P < 0.001) in the percentage of patients colonised/infected by Klebsiella spp. Reference 2 years Adult ICU Education on hand washing, hand hygiene observation, performance feedback Compliance increase from 14% to 73% (before patient contact) and from 28% to 81% (after patient contact) Significant reduction (P ¼ 0.02) in HCAI rates (from 33% to 12% and from 33% to 10%, respectively, after two intervention periods 4 years apart) 6 years Adult ICU Hand-washing promotion Compliance increase from 22% to 29.9% No impact on HCAI rates 11 months Adult ICUs Prospective multiple crossover trial on hand hygiene with either chlorhexidine soap or 60% isopropyl alcohol with optional hand washing with plain soap NA Significant reduction (P < 0.02) in HCAI rates using hand washing with chlorhexidine soap 8 months NICU Introduction of hand washing with triclosan 1% (w/v) NA Elimination of MRSA, when combined with multiple other infection control measures. Significant reduction (P < 0.02) in nosocomial bacteraemia (from 2.6% to 1.1%) using triclosan compared with chlorhexidine for hand washing 9 months Newborn nursery Introduction of HCWs hand washing and neonates bathing with triclosan 0.3% (w/v) NA Control of MRSA outbreak 3.5 years MICU/NICU Organisational climate intervention NA Significant (85%) relative reduction (P ¼ 0.02) in VRE rate in the intervention hospital; statistically not significant (44%) relative reduction in control hospital; no significant change in MRSA 8 months 28

21 Hand hygiene and HCAI prevention Hospital-wide Alcohol-based hand rub introduction, hand hygiene observation, training, performance feedback, posters 2003 Orthopaedic surgical unit Alcohol-based hand rub introduction, posters, feedback on HCAI rates, patient education and involvement 2004 Hospital-wide Alcohol-based hand rub introduction, hand hygiene observation, posters, performance feedback, informal discussions 2004 Adult intermediate care unit Hand hygiene electronic monitoring at exit from patient rooms, direct observation and voice prompts 2004 NICU Alcohol-based hand rub introduction, hand hygiene observation, training, hand-hygiene protocols, posters 2004 NICU Education, written instructions, hand hygiene observation, posters, performance feedback, financial incentives Significant increase in compliance from 48% to 66% Significant reduction (P ¼ 0.04 and P < 0.001) in the annual overall HCAI prevalence (42%) and MRSA cross-transmission rates (87%). Active surveillance cultures and contact precautions implemented during same period. A follow-up study showed continuous increase in hand rub use, stable HCAI rates and cost savings. NA 36% decrease (P value, NA) in HCAI (mainly urinary tract infection and SSI) rates (from 8.2% to 5.3%) No significant increase in compliance before and after patient contact Significant reduction (P ¼ 0.03) in hospital-acquired MRSA cases (from 1.9% to 0.9%) Compliance increase from 19.1% to 27.3% by electronic monitoring Reduction in HCAI rates (not statistically significant, P value, NA) Compliance increase from 40% to 53% (before patient contact) and from 39% to 59% (after patient contact) Reduction (P ¼ 0.14) in HCAI rates (from 11.3 to 6.2 per 1000 patient-days) Compliance increase from 43% to 80% Significant reduction (P ¼ 0.003) in HCAI rates (from 15.1 to 10.7 per 1000 patient-days), in particular for respiratory infections 8 years 29,30 10 months 31 1 year months 33 6 months 34 2 years 35 (continued on next page)

22 310 B. Allegranzi, D. Pittet Table I (continued) Year Hospital setting 2005 Hospital-wide Alcohol-based hand rub introduction, hand hygiene observation, training, posters Intervention Impact on hand hygiene compliance Compliance increase from 62% to 81% Impact on HCAI Duration of follow-up Significant reduction (P ¼ 0.01) in hospital-associated rotavirus infections Reference 4 years Adult ICUs Hand-washing observation, training, guideline dissemination, posters, performance feedback Compliance increase from 23.1% to 64.5% Significant reduction (P < 0.001) in HCAI rates (from 47.5 to 27.9 per 1000 patient-days) 21 months Hospital-wide Alcohol-based hand rub introduction, hand hygiene observation, training, posters, promotional gadgets Compliance increase from 21% to 42% Significant reduction (57%, P ¼ 0.01) in MRSA bacteraemia 36 months Neurosurgery Alcohol-based hand rub introduction, training, posters NA Reduction (54%, P ¼ 0.09) in overall incidence of SSI. Significant reduction (100%, P ¼ 0.007) in superficial SSI rates 2 years Neonatal unit Posters, focus groups, hand hygiene observation, HCWs perception assessment, feedback on performance, perception and HCAI rates Compliance increase from 42% to 55% Reduction (P value, NA) in overall HCAI rates (from 11 to 8.2 infections per 1000 patient-days) and 60% decrease (P value NA) in risk of HCAI in very low birth weight neonates (from 15.5 to 8.8 episodes per 1000 patient-days) 27 months ICU Prospective, controlled, cross-over trial in two units with education, posters and alcoholbased hand rub introduction Compliance increase from 38e37% to 68e69% No impact on device-associated infection and infections due to multidrug-resistant pathogens 2 years 41

The trinity of infection management: United Kingdom coalition statement

The trinity of infection management: United Kingdom coalition statement * The trinity of infection management: United Kingdom coalition statement This coalition statement, on behalf of our organizations (the UK Sepsis Trust, Royal College of Nursing, Infection Prevention Society,

More information

MRSA in the United Kingdom status quo and future developments

MRSA in the United Kingdom status quo and future developments MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L

More information

Promoting Appropriate Antimicrobial Prescribing in Secondary Care

Promoting Appropriate Antimicrobial Prescribing in Secondary Care Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR

More information

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?

More information

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention

More information

Board Meeting Agenda Item: 7.2 Paper No: Purpose: For Information. Healthcare Associated Infection Report

Board Meeting Agenda Item: 7.2 Paper No: Purpose: For Information. Healthcare Associated Infection Report Board Meeting 9.. Agenda Item: 7. Paper No: 6- Purpose: For Information Healthcare Associated Infection Report August/September Board Meeting 9.. Agenda Item: 7. Paper No: 6- Purpose: For Information August/September

More information

Screening programmes for Hospital Acquired Infections

Screening programmes for Hospital Acquired Infections Screening programmes for Hospital Acquired Infections European Diagnostic Manufacturers Association In Vitro Diagnostics Making a real difference in health & life quality June 2007 HAI Facts Every year,

More information

The importance of infection control in the era of multi drug resistance

The importance of infection control in the era of multi drug resistance Dr. Kumar Consultant Infectious Diseases Physician Hospital Sungai buloh The importance of infection control in the era of multi drug resistance Nosocomial infections In Australian acute hospitals 200,000

More information

Infection control in intensive care. Sandra Fairley Senior Nurse, Neurocritical Care

Infection control in intensive care. Sandra Fairley Senior Nurse, Neurocritical Care Infection control in intensive care Sandra Fairley Senior Nurse, Neurocritical Care sandra.fairley@uclh.nhs.uk Risks to the patient of health care acquired infection (HCAI) Patient admitted to hospital

More information

Antibiotic stewardship Implementing Strategies

Antibiotic stewardship Implementing Strategies 2 nd Joint Conference on the Antimicrobial Resistance Action Plan (AMRAP) and the Strategy for the Control of Antimicrobial Resistance in Ireland (SARI) 1. Background Antibiotic stewardship Implementing

More information

Policy Forum. Environmental and Professional Hygiene: Toward the Prevention of Drug Resistant Infections

Policy Forum. Environmental and Professional Hygiene: Toward the Prevention of Drug Resistant Infections Policy Forum Environmental and Professional Hygiene: Toward the Prevention of Drug Resistant Infections International Society of Microbial Resistance and Office of International Medical Policy School of

More information

Hand disinfection Topics

Hand disinfection Topics Hand disinfection Mongolia 2011 Walter Popp, Hospital Hygiene, University Clinics Essen, Germany 1 Topics History Hand washing vs. hand disinfection Importance of hand disinfection Compliance campaigns

More information

Overview of Infection Control and Prevention

Overview of Infection Control and Prevention Overview of Infection Control and Prevention Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry Green and Salah Gammouh

More information

Hospital Acquired Infections in the Era of Antimicrobial Resistance

Hospital Acquired Infections in the Era of Antimicrobial Resistance Hospital Acquired Infections in the Era of Antimicrobial Resistance Datuk Dr Christopher KC Lee Infectious Diseases Unit Department of Medicine Sungai Buloh Hospital Patient Story 23 Year old female admitted

More information

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY MDROs and Hand Hygiene Guidelines HH Apr14 The Science of Hand Hygiene in Healthcare Settings

More information

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health

More information

Quality indicators and outcomes in the devolved nations Scotland

Quality indicators and outcomes in the devolved nations Scotland Quality indicators and outcomes in the devolved nations Scotland Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Federation of Infection Societies Conference Birmingham,

More information

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov

More information

Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist

Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist philip.howard2@nhs.net Twitter: @AntibioticLeeds United Kingdom of England, Scotland, Wales & Northern Ireland

More information

Horizontal vs Vertical Infection Control Strategies

Horizontal vs Vertical Infection Control Strategies GUIDE TO INFECTION CONTROL IN THE HOSPITAL Chapter 14 Horizontal vs Vertical Infection Control Strategies Author Salma Abbas, MBBS Michael Stevens, MD, MPH Chapter Editor Shaheen Mehtar, MBBS. FRC Path,

More information

Quality and Safety Committee

Quality and Safety Committee SUMMARY REPORT Quality and Safety Committee ABM University Health Board Meeting On 20 TH OCTOBER 2016 Subject Prepared by Approved & Presented by Purpose Big Fight Campaign AGENDA ITEM: 2.2 Debra Woolley

More information

Summary of the latest data on antibiotic resistance in the European Union

Summary of the latest data on antibiotic resistance in the European Union Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network

More information

Other Enterobacteriaceae

Other Enterobacteriaceae GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 50: Other Enterobacteriaceae Author Kalisvar Marimuthu, MD Chapter Editor Michelle Doll, MD, MPH Topic Outline Topic outline - Key Issues Known

More information

ANTIMICROBIAL STEWARDSHIP IN SCOTLAND. Key achievements of the Scottish Antimicrobial Prescribing Group

ANTIMICROBIAL STEWARDSHIP IN SCOTLAND. Key achievements of the Scottish Antimicrobial Prescribing Group ANTIMICROBIAL STEWARDSHIP IN SCOTLAND Key achievements of the Scottish Antimicrobial Prescribing Group Dr Jacqueline Sneddon Project Lead Scottish Antimicrobial Prescribing Group Overview of talk ScotMARAP

More information

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier

More information

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University

More information

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we

More information

Medical Director Board Paper No. 10/43. Healthcare Associated Infection Reporting Template (HAIRT)

Medical Director Board Paper No. 10/43. Healthcare Associated Infection Reporting Template (HAIRT) NHS Board Meeting th October Medical Director Board Paper No. /3 Recommendation: Healthcare Associated Infection Reporting Template (HAIRT) The NHS Board is asked to note the latest monthly report on HAI

More information

Surveillance of AMR in PHE: a multidisciplinary,

Surveillance of AMR in PHE: a multidisciplinary, Surveillance of AMR in PHE: a multidisciplinary, integrated approach Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright International

More information

Staphylococcus aureus and Health Care associated Infections

Staphylococcus aureus and Health Care associated Infections Staphylococcus aureus and Health Care associated Infections Common - but poorly measured Prof Peter Collignon The Canberra Hospital Australian National University What are health-care associated infections?

More information

Multi-Drug Resistant Organisms (MDRO)

Multi-Drug Resistant Organisms (MDRO) Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause

More information

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection

More information

WELSH HEALTH CIRCULAR

WELSH HEALTH CIRCULAR WELSH HEALTH CIRCULAR WHC/2018/020 Issue Date: 4 May 2018 STATUS: ACTION & INFORMATION CATEGORY: QUALITY AND SAFETY Title: AMR IMPROVEMENT GOALS & HCAI REDUCTION EXPECTATIONS BY MARCH 2019: PRIMARY & SECONDARY

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Hand Hygiene CHAPTER 6: Authors A. J. Stewardson, MBBS, PhD D. Pittet, MD, MS

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Hand Hygiene CHAPTER 6: Authors A. J. Stewardson, MBBS, PhD D. Pittet, MD, MS GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 6: Hand Hygiene Authors A. J. Stewardson, MBBS, PhD D. Pittet, MD, MS Chapter Editor Shaheen Mehtar, MD, MBBS, FRC Path, FCPath (Micro) Topic Outline

More information

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)] United Nations A/RES/71/3 General Assembly Distr.: General 19 October 2016 Seventy-first session Agenda item 127 Resolution adopted by the General Assembly on 5 October 2016 [without reference to a Main

More information

ANTIBIOTIC STEWARDSHIP

ANTIBIOTIC STEWARDSHIP ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized

More information

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22 December 2005 COM (2005) 0684 REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION

More information

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT 1 REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT The Department of Health organised a summit on Antimicrobial Resistance (AMR) the purpose of which was to bring together all stakeholders involved

More information

Antimicrobial Stewardship in Scotland

Antimicrobial Stewardship in Scotland Antimicrobial Stewardship in Scotland UKCPA/FIS Scientific Meeting 18 th November 2010 Triumphs and Unintended Consequences Dr Jacqueline Sneddon Project Lead for Scottish Antimicrobial Prescribing Group

More information

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting

Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting COUNCIL OF THE EUROPEAN UNION Council Conclusions on Antimicrobial Resistance (AMR) 2876th EMPLOYMT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS Council meeting Luxembourg, 10 June 2008 The Council adopted

More information

POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS

POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS POTENTIAL STRUCTURE INDICATORS FOR EVALUATING ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN EUROPEAN HOSPITALS Dirk VOGELAERS Department of General Internal Medicine, Infectious Diseases and Psychosomatic Medicine

More information

Antimicrobial resistance (EARS-Net)

Antimicrobial resistance (EARS-Net) SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,

More information

Draft ESVAC Vision and Strategy

Draft ESVAC Vision and Strategy 1 2 3 7 April 2016 EMA/326299/2015 Veterinary Medicines Division 4 5 6 Draft Agreed by the ESVAC network 29 March 2016 Adopted by ESVAC 31 March 2016 Start of public consultation 7 April 2016 End of consultation

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/ EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health and food audits and analysis REFERENCES: ECDC, MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; 2017 DG(SANTE)/2017-6248 EXECUTIVE SUMMARY

More information

European Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE. 6 December 2011

European Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE. 6 December 2011 European Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE 6 December 2011 Address requests about publications of the WHO Regional Office for Europe to: Publications

More information

Healthcare Facilities and Healthcare Professionals. Public

Healthcare Facilities and Healthcare Professionals. Public Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:

More information

Antimicrobial Stewardship in the Hospital Setting

Antimicrobial Stewardship in the Hospital Setting GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi Antimicrobial Stewardship-way forward Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi Lets save what we have! What is Antibiotic stewardship? Optimal selection, dose and duration of

More information

Healthcare-associated infections surveillance report

Healthcare-associated infections surveillance report Healthcare-associated infections surveillance report Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q3 of 2017/18 Summary Table Q3 2017/18 Previous quarter (Q2 2017/18) Same quarter of previous

More information

Overview of Canada's Federal Actions to Address Antimicrobial Resistance and Antibiotic Stewardship

Overview of Canada's Federal Actions to Address Antimicrobial Resistance and Antibiotic Stewardship Overview of Canada's Federal Actions to Address Antimicrobial Resistance and Antibiotic Stewardship Jacqueline Arthur, RN, BScN Centre for Communicable Diseases and Infection Control Commonwealth Laboratory

More information

The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa

The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa The South African AMR strategy 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa Background to AMR 2 What is Antimicrobial stewardship and

More information

Hospital Infection. Mongolia, October Walter Popp Hospital Hygiene University Clinics Essen, Germany

Hospital Infection. Mongolia, October Walter Popp Hospital Hygiene University Clinics Essen, Germany Hospital Infection Mongolia, October 2011 Walter Popp Hospital Hygiene University Clinics Essen, Germany 1 2 1 3 4 2 Tuberculosis Mongolia: 4,218 new cases in 2010. 156 per 100,000. 000 Transmission possible

More information

Monthly Webinar. Tuesday 16th January 2018, 16:00. That Was The Year That Was : Selections from the 2017 Antimicrobial Stewardship Literature

Monthly Webinar. Tuesday 16th January 2018, 16:00. That Was The Year That Was : Selections from the 2017 Antimicrobial Stewardship Literature Monthly Webinar Tuesday 16th January 2018, 16:00 That Was The Year That Was : Selections from the 2017 Antimicrobial Stewardship Literature Audio dial-in (phone): 01 526 0058 Instructions Interactive Please

More information

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship J. Hudson Garrett Jr., PhD, MSN, MPH, FNP-BC, PLNC, CDONA, IP-BC, GDCN, CDP, CADDCT, CALN, VA-BC, AS-BC,

More information

How to get senior hospital and clinical engagement

How to get senior hospital and clinical engagement How to get senior hospital and clinical engagement Professor Alison Holmes Professor of Infectious Diseases Director, NIHR Health Protection Research Unit: HCAI and AMR Engagement through Organisational

More information

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an

More information

What is an Antibiotic Stewardship Program?

What is an Antibiotic Stewardship Program? What is an Antibiotic Stewardship Program? Jane Rogers, R.N. Anne Messer, MPH Learning Session #4 August 15, 2017 National Nursing Home Quality Care Collaborative Change Package Change Bundle: To prevent

More information

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org

More information

Antimicrobial Resistance Update for Community Health Services

Antimicrobial Resistance Update for Community Health Services Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs

More information

Healthcare-associated Infections and Antimicrobial Use Prevalence Survey

Healthcare-associated Infections and Antimicrobial Use Prevalence Survey Healthcare-associated Infections and Antimicrobial Use Prevalence Survey Shamima Sharmin, M.B.B.S., MSc, MPH Emerging Infections Program New Mexico Department of Health Agenda Recognize healthcare-associated

More information

Antimicrobial Stewardship Northern Ireland

Antimicrobial Stewardship Northern Ireland Antimicrobial Stewardship Northern Ireland Dr Lorraine Doherty Assistant Director of Public Health (Health Protection) Public Health Agency 15 November 2011 Co Authors Dr Muhammad Sartaj. SpR Public Health

More information

Hosted by Dr. Jon Otter, Guys & St. Thomas Hospital, King s College, London A Webber Training Teleclass 1

Hosted by Dr. Jon Otter, Guys & St. Thomas Hospital, King s College, London A Webber Training Teleclass   1 Andreas Voss, MD, PhD Professor of Infection Control Radboud University Nijmegen Medical Centre & Canisius-Wilhelmina Hospital Nijmegen, Netherlands Hosted by Dr. Jon O0er Guys & St. Thomas NHS Founda

More information

So Why All the Fuss About Hand Hygiene?

So Why All the Fuss About Hand Hygiene? CARING PROFESSIONAL SERVICES, INC. HAND HYGIENE In-Service So Why All the Fuss About Hand Hygiene? Most common mode of transmission of pathogens is via hands! Infections acquired in healthcare Spread of

More information

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL SECOND REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION (2002/77/EC) ON THE PRUDENT USE OF ANTIMICROBIAL AGENTS IN HUMAN

More information

28/08/2017. Infection Prevention and Control. Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR

28/08/2017. Infection Prevention and Control. Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR 2017 Safe Patient Care 2017: The Ongoing Challenge of MDROs and AMR Management of the Patient Environment in relation to Multidrug

More information

Preventing Clostridium difficile Infection (CDI)

Preventing Clostridium difficile Infection (CDI) 1 Preventing Clostridium difficile Infection (CDI) All Hands on Deck to Reduce CDI Skill Nursing Facility Conference July 28, 2017 Idamae Kennedy, MPH,BSN,RN,CIC Liaison Infection Preventionist Healthcare

More information

Epidemiology and Economics of Antibiotic Resistance

Epidemiology and Economics of Antibiotic Resistance Epidemiology and Economics of Antibiotic Resistance Eili Y. Klein February 17, 2016 Health Watch USA Meeting I. The burden of antibiotic resistance is a growing global threat, but hard numbers are lacking

More information

Third Global Patient Safety Challenge. Tackling Antimicrobial Resistance

Third Global Patient Safety Challenge. Tackling Antimicrobial Resistance Geneva 12 th -13 th March 2009 Day 1, 12 th March Third Global Patient Safety Challenge Tackling Antimicrobial Resistance Edward Kelly, Coordinator, WHO Patient Safety Programme welcomed all participants

More information

Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C. Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune

Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C. Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune Combating Antibiotic Resistance: New Drugs 4 Bad Bugs (ND4BB) Subtopic 1C Seamus O Brien and Hasan Jafri Astra Zeneca and MedImmune Need for public-private collaboration Challenges of AB R&D: 1. Unique

More information

ANTIMICROBIALS PRESCRIBING STRATEGY

ANTIMICROBIALS PRESCRIBING STRATEGY Directorate of Operations Clinical Support Services Diagnostic Services Pharmacy ANTIMICROBIALS PRESCRIBING STRATEGY Reference: DCM021 Version: 2.0 This version issued: 25/04/16 Result of last review:

More information

Antimicrobial stewardship in companion animals: Welcome to a whole new era

Antimicrobial stewardship in companion animals: Welcome to a whole new era Antimicrobial stewardship in companion animals: Welcome to a whole new era John F. Prescott, University Professor Emeritus, Department of Pathobiology, University of Guelph, Guelph, Ontario NG 2W1 prescott@uoguelph.ca

More information

Changing behaviours in antimicrobial stewardship

Changing behaviours in antimicrobial stewardship Changing behaviours in antimicrobial stewardship Esmita Charani, MPharm, MSc Academic Research Pharmacist, PhD Candidate National Institute of Health Research Health Protection Unit Imperial College London

More information

Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance. Ceredigion and Mid Wales Trust Data per Bed Days

Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance. Ceredigion and Mid Wales Trust Data per Bed Days Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance Ceredigion and Mid Wales Trust Data per 100 000 Bed Days Commentary: Staphylococcus aureus is a bacterium that a proportion (up to

More information

Jump Starting Antimicrobial Stewardship

Jump Starting Antimicrobial Stewardship Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 4: Antibiotic Resistance Author M.P. Stevens, MD, MPH S. Mehtar, MD R.P. Wenzel, MD, MSc Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues

More information

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention Highlights for the Medical Staff Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention Standard Precautions every patient every time a. Hand Hygiene b. Use of Personal Protective Equipment (PPE)

More information

Handwashing behavior change in health facilities. July 11 th 2018

Handwashing behavior change in health facilities. July 11 th 2018 Handwashing behavior change in health facilities July 11 th 2018 Impact of handwashing in healthcare settings Recommended and current practice Examples of behavior change approaches and drivers/ barriers

More information

What Canadian vets need to know and explain about antimicrobial resistance

What Canadian vets need to know and explain about antimicrobial resistance What Canadian vets need to know and explain about antimicrobial resistance By John F. Prescott, MA, VetMB, PhD Major changes are underway regarding how agricultural use of antibiotics is regulated in food

More information

Surgical prophylaxis for Gram +ve & Gram ve infection

Surgical prophylaxis for Gram +ve & Gram ve infection Surgical prophylaxis for Gram +ve & Gram ve infection Professor Mark Wilcox Clinical l Director of Microbiology & Pathology Leeds Teaching Hospitals & University of Leeds, UK Heath Protection Agency Surveillance

More information

Antimicrobial Stewardship: The South African Perspective

Antimicrobial Stewardship: The South African Perspective Antimicrobial Stewardship: The South African Perspective Precious Matsoso Director General; National Department of Health; South Africa 13 th November 2015 Why do we need an AMR strategy and implementation

More information

Future Directions: Public Health The example of antimicrobial resistance

Future Directions: Public Health The example of antimicrobial resistance Future Directions: Public Health The example of antimicrobial resistance Valuing Our Life Support Systems Natural Capital Initiative British Library, 7 November 2014 Professor Anthony Kessel Director of

More information

MRSA found in British pig meat

MRSA found in British pig meat MRSA found in British pig meat The first evidence that British-produced supermarket pig meat is contaminated by MRSA has been found in new research commissioned by The Alliance to Save Our Antibiotics

More information

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical

More information

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries 30 APRIL 2014 GENEVA - A new report by WHO its first to look at antimicrobial resistance,

More information

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC MDRO s, Stewardship and Beyond Linda R. Greene RN, MPS, CIC linda_greene@urmc.rochester.edu Evolving Threat of Antimicrobial Resistance Why are MDROs important? Limited treatment options Associated with:

More information

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics Priority Topic B Diagnostics Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics The overarching goal of this priority topic is to stimulate the design,

More information

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic

More information

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University

More information

Kenya SSH4A Results Programme first mid-term review brief

Kenya SSH4A Results Programme first mid-term review brief Practice Brief Kenya SSHA Results Programme first mid-term review brief Over the course of one year,5 people in four counties in Kenya gained access to sanitation facilities, 5,07 people began practising

More information

National Action Plan development support tools

National Action Plan development support tools National Action Plan development support tools Sample Checklist This checklist was developed to be used by multidisciplinary teams in countries to assist with the development of their national action plan

More information

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

Antibiotic resistance is one of the biggest threats to global health, food security, and development today. Antibiotic resistance Fact sheet Updated November 2017 Key facts Antibiotic resistance is one of the biggest threats to global health, food security, and development today. Antibiotic resistance can affect

More information

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Dr Eleri Davies Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Antimicrobial stewardship What is it? Why is it important? Treatment and management of catheter-associated

More information

Healthcare-associated Infections Annual Report December 2018

Healthcare-associated Infections Annual Report December 2018 December 2018 Healthcare-associated Infections Annual Report 2011-2017 TABLE OF CONTENTS INTRODUCTION... 1 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS... 2 MRSA SURVEILLANCE... 3 CLOSTRIDIUM

More information

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals National Center for Emerging and Zoonotic Infectious Diseases Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals Denise Cardo, MD Director, Division of Healthcare Quality Promotion,

More information

Antimicrobial Resistance (2013)

Antimicrobial Resistance (2013) Antimicrobial Resistance (2013) In the second half of 2013, the NIHR issued a call for research into the evaluation of public health measures, health care interventions and health services to reduce the

More information

Is biocide resistance already a clinical problem?

Is biocide resistance already a clinical problem? Is biocide resistance already a clinical problem? Stephan Harbarth, MD MS University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland Important points Biocide resistance exists Antibiotic

More information

Dr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune

Dr. P. P. Doke. M.D., D.N.B., Ph.D., FIPHA. Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune Dr. P. P. Doke M.D., D.N.B., Ph.D., FIPHA Professor, Department of Community Medicine, Bharati Vidyapeeth Medical College, Pune 1 Anti microbial resistance is now a global geometrically increasing threat

More information

Initiatives for Addressing Antimicrobial Resistance in the Environment. Executive Summary

Initiatives for Addressing Antimicrobial Resistance in the Environment. Executive Summary Initiatives for Addressing Antimicrobial Resistance in the Environment Executive Summary This executive summary highlights key themes from a scientific white paper and discussion at the International Environmental

More information